Newsroom

"We need heroes to help dying patients."…
Could 100 Be the New 60?
Fighting Age-Related Muscle Loss
Astronaut Buzz Aldrin Relies on Re Muscl…
Dr. Robert J. Hariri Chairman of MYOS Co…
The Government’s Bad Diet Advice
Raw Eggs and No Husband Since ’38 Keep…
Chairman Dr. Robert Hariri of MYOS Corpo…
US egg consumption grows for a fifth con…
Huff Post conversation with MYOS Chairma…
Founder and Chairman of MYOS Corporation…
Equities.com Interviews MYOS Chief Medic…
Eat to Beat Sarcopenia: Foods That Won't…
White Paper: The Effect of Fortetropin o…
BioWorld: “In The Clinic” Spotlights…
MYOS Reports Positive Top-Line Clinical …
BioWorld: “Myos, Cloud collaborate to …
“Contact Light” - A Tribute To MYOS …
Biotech Visionaries Venter, Hariri and D…
Scientific American worldVIEW Includes M…
MYOS Chairman Robert Hariri to speak at …
Why MYOS? One-on-One With MYOS General C…
Letterman's Doctor and MYOS Board Member…
Optimal Wellness Radio Hour Featuring MY…
Why MYOS? One-on-One With Maghsoud Daria…
MYOS Corporation Featured in Muscle & Fi…
MYOS Corporation to Present at the Third…
Why MYOS? One-on-One With CMO Dr. Robert…
The Courage to Change the World
The Life Sciences Report Interview With …
MYOS Corp. announces appointment of DosS…
Why MYOS? One-on-One With President and …
"Drugs Aim to Help Elderly Rebuild Muscl…
Sarcopenia and the FDA: A Time for Chan…
Diamandis Named 50 Greatest Leaders
Follow MYOS on Social Media!
20
May

Why MYOS? One-on-One With President and COO Peter Levy

Today, we introduce you to MYOS President and Chief Operating Officer Peter Levy. Levy, who comes to MYOS Corporation with an impressive career as a practicing attorney, CPA firm partner, SEC integrity monitor and CEO of another publicly traded company, says the key reason he wanted to join the MYOS team is because of founder Dr. Robert Hariri. “Bob’s vision for MYOS, both in terms

28
April

MYOS Executive Chairman Robert Hariri, MD, PhD Responds to WSJ Article: “Drugs Aim to Help Elderly Rebuild Muscle”

The Wall Street Journal this morning released an article touting the significant developments being made in the field of myostatin inhibitors and muscle health research. MYOS Corporation, a bionutrition and biotherapeutics company, is a key player in the field of muscle health. In addition to focusing on the development and commercialization of products that improve the muscle function

09
April

Sarcopenia and the FDA: A Time for Change?

Rather than retrofit existing regulations, perhaps it’s time to start fresh, taking into account emerging science on muscle performance and it’s impact on healthy aging. There are many studies that show skeletal muscle strength is a good indication of overall health and well-being. Evidence of a product or activity that increases muscle strength is also pretty straightforward.

26
March

MYOS Board Member Peter Diamandis Named Top 50 Greatest Leaders by Fortune Magazine

MYOS Corporation board member and independent director Peter Diamandis, MD, was recently named one of the world’s top 50 greatest leaders by Fortune Magazine. Diamandis, who joined MYOS in 2011, is also Chairman and CEO of X PRIZE Foundation, a non-profit organization that creates large-scale incentivized prize competitions that lead to global innovations to benefit humanity.

19
March

Make a Difference by Following MYOS on Social Media!

Follow MYOS on Facebook, Twitter, Google+ and LinkedIn to Raise Money for the Muscular Dystrophy Association (MDA)! This Sunday, March 23rd, MYOS will participate in the New Jersey MDA Muscle Walk fundraising event at the Prudential Center in Newark, NJ. MYOS employees, affiliates and their families have teamed up to pay tribute to children and adults served by the Muscular

14
March

Robert Hariri, MD, PhD: “We need heroes to help dying patients.”

As thousands joined the fight over the past few weeks to save Josh Hardy’s life by lobbying drug company Chimerix to allow the dying boy access to its potentially life-saving treatment, supporters finally received the news they’d been hoping for on Tuesday evening. In a statement late in the day, Chimerix CEO Kenneth I. Moch confirmed that the FDA had approved an

12
March

Could 100 Be the New 60?

The recent founding of Human Longevity Inc. combined with the groundbreaking work of MYOS could hold the key to longer lifespans. MYOS Corporation founder Robert Hariri, MD, PhD announced last week the formation of Human Longevity Inc. (HLI), a new company co-founded by Hariri, Peter H. Diamandis, MD and J. Craig Venter, PhD. The new genomics and cell